These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33486019)

  • 1. Enhanced drug loading of in situ forming gels for oral mucositis pain control.
    Li T; Lalla RV; Burgess DJ
    Int J Pharm; 2021 Feb; 595():120225. PubMed ID: 33486019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoadhesive in situ forming gel for oral mucositis pain control.
    Li T; Bao Q; Shen J; Lalla RV; Burgess DJ
    Int J Pharm; 2020 Apr; 580():119238. PubMed ID: 32194210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
    Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
    Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and characterization of calcium-free in-situ gel formulation based on sodium alginate and chitosan.
    Belhadji L; HadjSadok A; Moulai-Mostefa N
    Drug Dev Ind Pharm; 2018 Apr; 44(4):662-669. PubMed ID: 29172753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of Ocular In Situ Gels with Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation In Vitro.
    Perminaite K; Marksa M; Stančiauskaitė M; Juknius T; Grigonis A; Ramanauskiene K
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34200887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.
    Moreira TS; de Sousa VP; Pierre MB
    J Pharm Pharm Sci; 2010; 13(2):286-302. PubMed ID: 20816013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of in situ novel intragastric controlled-release formulation of hydrochlorothiazide.
    Patel RR; Patel JK
    Acta Pharm; 2011 Mar; 61(1):73-82. PubMed ID: 21406345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of an injectable in situ forming gel for sustained-release of Ivermectin in vitro and in vivo.
    Geng Z; Luo X; Zhang Z; Li H; Tian J; Yu Z
    Int J Biol Macromol; 2016 Apr; 85():271-6. PubMed ID: 26708436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
    Mansour M; Mansour S; Mortada ND; Abd Elhady SS
    Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels.
    Yu Z; Guo F; Guo Y; Zhang Z; Wu F; Luo X
    PLoS One; 2017; 12(3):e0173949. PubMed ID: 28350799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of novel in situ gels containing acyclovir for the treatment of oral herpes simplex virus infections.
    Chaudhary B; Verma S
    ScientificWorldJournal; 2014; 2014():280928. PubMed ID: 24790559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
    Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
    Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on solution-to-gel characteristic of thermosensitive and mucoadhesive biopolymers for the development of moxifloxacin-loaded sustained release periodontal in situ gels.
    Sheshala R; Quah SY; Tan GC; Meka VS; Jnanendrappa N; Sahu PS
    Drug Deliv Transl Res; 2019 Apr; 9(2):434-443. PubMed ID: 29392681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ gelling pectin formulations for oral drug delivery at high gastric pH.
    Itoh K; Hirayama T; Takahashi A; Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2007 Apr; 335(1-2):90-96. PubMed ID: 17141988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of indomethacin Carbopol ETD 2001 gels and the influence of storage time and temperature on their stability.
    Shawesh AM; Kaukonen A; Kallioinen S; Antikainen O; Yliruusi J
    Pharmazie; 2003 Feb; 58(2):130-5. PubMed ID: 12641331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
    Ur-Rehman T; Tavelin S; Gröbner G
    Int J Pharm; 2011 May; 409(1-2):19-29. PubMed ID: 21335076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.